It’s an absolute pharmaceutical revolution as eMed CEO Linda Yaccarino and Chief Wellness Officer, seven-time Super Bowl champion, and FOX Sports lead NFL analyst Tom Brady join the Claman Countdown to talk about democratizing affordable, FDA-approved GLP-1 access through employers.
Linda highlights how eMed leverages AI and clinical support to double industry standards for patient adherence, and Tom shares how he is translating his legendary NFL discipline straight into the corporate workforce. Later, he discusses his third season in the FOX Sports booth and his expectations for the Las Vegas Raiders' rookie quarterback
Fernando Mendoza.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
